Neonatal acute respiratory failure

Current Opinion in Pediatrics

Volumn 12, Issue 3, 2000, Pages 227-232

  Gnanaratnem, Jeevarathi ^a   Finer, Neil N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; LUNG SURFACTANT; NITRIC OXIDE; STEROID; SURFACTANT;

ACUTE RESPIRATORY FAILURE; ARTICLE; CONGENITAL DIAPHRAGM HERNIA; CORTICOSTEROID THERAPY; EXTRACORPOREAL OXYGENATION; HIGH FREQUENCY VENTILATION; HYPERCAPNIA; LUNG HYPOPLASIA; MECONIUM ASPIRATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN INTENSIVE CARE; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEPSIS; TREATMENT PLANNING;

ACUTE DISEASE; COMBINED MODALITY THERAPY; HUMANS; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY INSUFFICIENCY; RISK FACTORS;

EID: 0034039728     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200006000-00009     Document Type: Article

References (75)

1. 1 Linde-Zwirble WT, Angus DC, Clermont G, Roberts MS, Coleman MB, Newbold RC, Goldstein M, Pinsky MR: Diagnoses associated with delivery of mechanical ventilation in the newborn [abstract]. Pediatr Res 1997, 41:1199.
2. 2 Liggins GC, Howie RN: A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972, 50:515-525.
3. 3 Croweley P, Chalmers I, Keirse MJNC: The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990, 97:11-25.
4. 4 Rennie JM, Wheater M, Cole TJ: Antenatal steroid administration is associated with an improved chance of intact survival in preterm infants. Eur J Pediatr 1996, 155:576-579.
5. 5 Crowley P: Prophylactic corticosteroids for preterm birth (Cochrane Review). In The Cochrane Library, Issue 4, 1999. Oxford: Update Software.
6. 6 Leviton A, Dammonn O, Allred EN, Kuban K, Pagano M, Van Marter L, et al.: Antenatal corticosteroids and cranial ultrasonographic abnormalities. Am J Obstet Gynecol 1999, 181:1007-1017.
7. 7 Baud O, Foix L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, et al.: Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. New Engl J Med 1999, 341:1190-1196.
8. 8 Kalchbrenner MA, Weisenborn EJ, Chyu JK, Kaufman HK, Losure TA: Delayed delivery of multiple gestations: Maternal and neonatal outcomes. Am J Obstet Gynecol 1998, 179:1145-1149.
9. 9 Ikegami M, Jobe AH, Newman J, Polk DH, Willet KE, Sly P: Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med 1997, 156:178-184.
10. 10 Slotkin TA, Zhang J, McCook EC, Seidler FJ: Glucocorticoid administration alters nuclear transcription factors in fetal rat brain: implications for the use of antenatal steroids. Develop Brain Res 1998, 111:11-24.
11. 11 Vermillion ST, Soper DE, Chasedunn-Roark J: Neonatal sepsis after betamethasone administration to patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1999, 181:320-327.
12. 12 French NP, Hagan R, Evans SF, Godfrey M, Newham JP: Repeated antenatal corticosteroids: Size at birth and subsequent development. Am J Obstet Gynecol 1999, 180:114-121.
13. 13 Elimian A, Verma U, Visintainer P, Tejani N: Effectiveness of multidose antenatal steroids. Obstet Gynecol 2000, 95:34-36.
14. 14 Hudak ML, Martin DJ, Egan EA, Matteson EJ, Cumming J, Jung AL, et al.: A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome. Pediatrics 1997, 100:39-50.
15. 15 Bloom BT, Kattwinkel J, Hall RT, Delmore PM, Egan EA, Trout JR, et al.: Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics 1997, 100:31-38.
16. 16 Hudak ML, Farrell EE, Rosenberg AA, Jung AL, Auten RL, Durand DJ, et al.: A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome. J Pediatr 1996, 128:396-406.
17. 17 Vaucher YE, Merritt TA, Hallman M, Jarvenpaa AL, Telsey AM, Jones BL: Neurodevelopmental and respiratory outcome in early childhood after human surfactant treatment. Am J Dis Child 1988, 142:927-930.
18. 18 Soll R, Morley C: Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants (Cochrane Review). In The Cochrane Library, Issue 4, 1999. Oxford: Update Software.
19. 19 Kendig JW, Ryan RM, Sinkin RA, Maniscalco WM, Notter RH, Guillet R, et al.: Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial. Pediatrics 1998, 101:1006-1012.
20. 20 Bhuta T, Ohlsson A: A systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1998, 79:26-33.
21. 21 Halliday HL, Ehrenkranz RA: Early postnatal (<96 hours) corticosteriods for preventing chronic lung disease in preterm infants (Cochrane Review). In The Cochrane Library, Issue 4, 1999. Oxford: Update Software.
22. 22 Halliday HL, Ehrenkranz RA: Moderately early (7-14 days) postnatal corticosteriods for preventing chronic lung disease in preterm infants (Cochrane Review). In The Cochrane Library, Issue 4, 1999. Oxford: Update Software.
23. 23 Halliday HL, Ehrenkranz RA: Delayed (> 3 weeks) postnatal corticosteriods for chronic lung disease in preterm infants (Cochrane Review). In The Cochrane Library, Issue 4, 1999. Oxford: Update Software.
24. 24 Vohr BR, Wright LL, Poole K: Effects of site differences at 12 participating NICHD centers on 18 month outcomes of extremely low birth weight (ELBW) < 1000 g infants: The NICHD Neonatal Research Outcome Study [abstract]. Pediatr Res 1999, 45:258.
25. 25 Vermont Oxford Network 1998 Database Summary. Vermont Oxford Network. Burlington, Vermont; 1999. Last update, December 1999.
26. 26 Stark AR, Carlo W, Bauer C, Donovan E, Oh W, Papile L, et al.: Complications of early steroid therapy in a randomized controlled trial [abstract]. Pediatrics 1999, 104(Part 3 of 3):739.
27. 27 Garland JS, Alex CP, Pauly TH, Whitehead VL, Brand J, Winston JF, et al.: A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics 1999, 104:91-99. This prospective, multicenter randomized trial, comparing a 3-day course of early dexamethasone therapy with placebo therapy showed that early dexamethasone therapy increases survival without CLD. Mortality rates were not significantly different. Early intestinal perforation was common among the subjects in the group treated with dexamethasone.
28. 28 Papile LA, Tyson JE, Stoll BJ, Wright LL, Donovan EF, Bauer CR, et al.: A multicenter trial of two dexamethasone regimens in ventilator dependent premature infants. New Engl J Med 1998, 338:1112-1118.
29. 29 Stoll BJ, Temprosa M, Tyson JE, Papile LA, Wright LL, Bauer CR, et at.: Dexamethasone therapy increases infection in very low birth weight infants. Pediatrics 1999, 104:e63. Available at: URL:http://www.pediatrics.org/cgi/content/full/104/5/e63.
30. 30 Van Goudoever JB, Wattimena JD, Carnielli VP, Sulkers EJ, Degenhart HJ, Sauer PJ: Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia. J Pediatr 1994, 124:112-118.
31. 31 Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, Hsieh WS, Lien YJ: Early dexamethasone therapy in preterm infants: a follow-up study. Pediatr 1998, 101:71-78.
32. 32 O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BG, Weaver RG 3rd, Dillard RG: Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 1999, 104:15-21.
33. 33 Shinwell ES, Karplus M, Zmora E, Reich D, Rothschild A, Blazer S, et al.: Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 1996, 74:33-37.
34. 34 Baud O, Zupan V, Lacze-Masmontiel T, Dehan M: Neurological adverse effects of early postnatal dexamethasone in very preterm infants [abstract]. Arch Dis Child Fetal Neonatal Ed 1999, 80:158.
35. 35 Watterberg KL, Gerdes JS, Gifford KL, Lin HM: Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants [abstract]. Pediatr 1999, 104:1258-1263. This study shows that early treatment with low dose hydrocortisone increases the likelihood of survival without CLD in extremely low birth weight infants.
36. 36 Gerstmann DR, Minton SD, Stoddard RA, Meredith KS, Monaco F, Bertrand JM, et al.: The Provo multicenter early high frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome. Pediatrics 1996, 98:1044-1057.
37. 37 Thome U, Kossel H, Lipowsky G, Porz F, Furste H, Genzel-Boroviceny O, et al.: Randomized comparison of high-frequency ventilation with high-rate intermittent positive pressure ventilation in preterm infants with respiratory failure. J Pediatr 1999, 135:39-46. This RCT shows that HFV with high lung volume strategy is not associated with less lung injury or increased risk of IVH in VLBW infants.
38. 38 Cools F, Offringa M: Meta-analysis of elective high frequency ventilation in preterm infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 1999, 80:15-20.
39. 39 Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan HB, Cotton RB, et al.: Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987, 79:26-30.
40. 40 Jónsson B, Katz-Salamon M, Faxelius G, Broberger U, Lagercrantz H: Neonatal care of very low birth weight infants in special care units and neonatal intensive care units in Stockholm: early nasal continuous positive airway pressure versus mechanical ventilation: gains and losses. Acta Pediatr Suppl 1997, 419:4-10.
41. 41 Gittermann MK, Fusch C, Gittermann AR, Regazzoni BM, Moessinger AC: Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birthweight infants. Eur J Pediatr 1997, 156:384-388.
42. 42 Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrøm K, Jacobsen T: Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. New Engl J Med 1994, 331:1051-1055.
43. 43 Verder H, Albertson P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, et al.: Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks gestation. Pediatr 1999, 103:e241-e246. Available at: URL: http://www.pediatrics.org/cgi/content/full/103/2/e241-e246. This study shows that nasal CPAP with early surfactant administration is safe and reduces the subsequent need for mechanical ventilation in infants younger than 30 weeks gestation who have RDS.
44. 44 Hickling KG, Walsh H, Henderson S, Jackson R: Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 1990, 16:372-377.
45. 2 used in the group treated with PHC in this study, 45 to 55 mmHg, is the norm used by most neonatologists.
46. 46 Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, et al.: Inhaled nitric oxide in premature neonates with severe hypoxemic respiratory failure: a randomized controlled trial. Lancet 1999, 354:1061-1065. This multicenter RCT done in 80 premature infants with severe acute respiratory failure reported that low dose INO improved oxygenation at 60 minutes after treatment but did not improve survival. Low dose INO did not increase the incidence of IVH or pulmonary hemorrhage in these infants.
47. 47 Subhedar NV, Shaw NJ: Changes in oxygenation and pulmonary haemodynamics in preterm infants treated with inhaled nitric oxide. Arch Dis Child Fetal Neonatal Ed 1997, 77:191-197.
48. 48 Meurs KP, Rhine WD, Asselin JM, Durand DJ: Response of premature infants with severe respiratory failure to inhaled nitric oxide: Preemie NO Collaborative Group. Pediatr Pulmonol 1997, 24:319-323.
49. 49 The Franco Belgium Collaborative NO Trial Group: Early compared with delayed inhaled nitric oxide in moderately hypoxic neonates with respiratory failure: a randomized controlled trial. Lancet 1999, 354:1066-1071.
50. 50 Goetzman BW, Sunshine P, Johnson JD, Wennberg RP, Hackel A, Merten DF, et al.: Neonatal hypoxia and pulmonary vasospasm: Response to tolazoline. J Pediatr 1976, 89:617-621.
51. 51 Drummond WH, Gregory GA, Heymann MA, Phibbs RA: The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension. J Pediatr 1981, 98:603-611.
52. 52 Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, et al.: Persistent pulmonary hypertension of the newborn in the era before nitric oxide; practice variation and outcomes. Pediatr 2000, 105:14-26. This group retrospectively looked at different treatments methods used in PPHN before using INO. Hyperventilation was used in 65% of patients studied, continuous alkali infusion used in 75%. Other treatments included sedation, paralysis, inotrope administration, and vasodilator drugs. Despite wide variation in practice, there was no significant difference in mortality among centers.
53. 53 Higenbottam T, Pepke-Zaba J, Scott J, Wollman P, Coutts C, Wallwork J: Inhaled endothelium-derived relaxing factor (EDRF) in primary pulmonary hypertension (PPH) [abstract]. Am Rev Respir Dis 1988, 137:107.
54. 54 Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J: Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991, 338:1173-1174.
55. 55 Roberts JD, Polaner DM, Lang P, Zapol WM: Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992, 340:818-819.
56. 56 Kinsella JP, Neish SR, Shaffer E, Abman SH: Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992, 340:819-820.
57. 57 Finer NN, Barrington KB: Nitric oxide for respiratory failure in infants born at or near term (Cochrane Review). In The Cochrane Library, Issue 2, 1999. Oxford: Update Software.
58. 58 The Neonatal Inhaled Nitric Oxide Study Group (NINOS): Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up. J Pediatr 2000, in press. This article reports on follow-up studies on infants treated with INO.
59. 59 Clark RH, Bradley LTC, Yoder A: Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 1994, 124:447-454.
60. 60 Engle WA, Yoder MC, Andreoli SP, Darragh RK, Langefeld CD, Hui SL: Controlled prospective randomized comparison of high-frequency ventilation and conventional ventilation in neonates with respiratory failure and persistent pulmonary hypertension. J Perinatol 1997, 17:3-9.
61. 61 Lotze A, Mitchell BR, Bulas DI, Zola EM, Shalwitz RA, Gunkel JH, and the Survanta in Term Infants Study Group: Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr 1998, 132:40-47.
62. 62 Lotze A, Knight GR, Martin GR, Bulas DI, Hull WM, O'Donnell RM, et al.: Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxgenation. J Pediatr 1993, 122:261-268.
63. 63 Findlay RD, Taeusch HW, Wather FJ: Surfactant replacement therapy for meconium aspiration syndrome. Pediatr 1996, 97:48-52.
64. 64 Cochrane CG, Revak SD, Merritt TA, Schraufstatter ID, Hoch RC, Henderson C, et al.: Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome. Pediatr Res 1999, 44:705-715.
65. 65 Wiswell TE, and the Surfaxin-Lavage for MAS Trial Group: Bronchoalveolar lavage with dilute Surfaxin (KL4-Surfactant for the management of the meconium aspiration syndrome (MAS) [abstract]. Pediatr Res 199, 45:326.
66. 66 Lam CC, Yeung CY: Surfactant lavage for meconium aspiration syndrome: a pilot study. Pediatrics 1999, 103:1014-1018.
67. 67 Pandit PB, Dunn MS, Colucci EA: Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics 1995, 95:32-36.
68. 68 Bartlett RH, Gazzaniga AB, Toomasian J, Coran AG, Roloff D, Rucker R, Coran AG: Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure: 100 cases. Ann Surg 1986, 204:236-245.
69. 69 O'Rourke PP, Crone RK, Vacanti JP, Ware JH, Lillehei CW, Parad RB, Epstein MF: Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics 1989, 84:957-963.
70. 70 UK Collaborative ECMO (extracorporeal membrane oxygenation) Trial group: UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996, 348:75-82.
71. 71 The Collaborative UK ECMO (Extracorporeal Membrane) trial: follow-up to 1 year of age. Pediatrics 1998, 4:101/e1. Available at: http://www.pediatrics.org/cgi/content/full/101/4/e1.
72. 72 The Neonatal Inhaled Nitric Oxide Study Group (NINOS): Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics 1997, 99:838-845.
73. 73 Finer NN, Tierney A, Etches PC, Peliowski A, Ainsworth W: Congenital diaphragmatic hernia: developing a protocolized approach. J Pediatr Surg 1998, 33:1331-1337.
74. 74 Somaschini M, Locatelli G, Salvoni L, Bellan C, Colombo A: Impact of new treatments for respiratory failure on outcome of infants with congenital diaphragmatic hernia. Eur J Pediatr 1999, 158:780-784. This group reports that preoperative stabilization using HFV, surfactant, INO, and ECMO improves outcome of infants with CDH.
75. 75 Harrison MR, Mychaliska GB, Albanese CT, Jennings RW, Farrell JA, Hawgood S, et al.: Correction of congenital diaphragmatic hernia in utero IX: fetuses with poor prognosis (liver herniation and low lung-to-head ratio) can be saved by fetoscopic temporary tracheal occlusion. J Pediatr Surg 1998, 33:1017-1022.